Skip to main content
IMAX
NYSE Industrial Applications And Services

CEO Gelfond Exercises Options, Sells $24M in IMAX Stock Near 52-Week High

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Media & Entertainment Stocks · Communication
Sentiment info
Negative
Importance info
7
Price
$52.74
Mkt Cap
$2.892B
52W Low
$25.555
52W High
$54.5
52W Position info
106% above low
Off High info
3.2% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

IMAX has more than doubled off its 52-week low of $25.555.

Summary

IMAX CEO Richard Gelfond exercised 356,757 options and sold the shares for $23.98M under a 10b5-1 plan, near the stock's 52-week high.


Key Events · Ownership and Investor Activity · IMAX

  • CEO Exercises Options and Sells

    Richard Gelfond exercised 356,757 stock options at $31.90 and sold all resulting shares for $23.98 million under a 10b5-1 plan.

  • Sale Near 52-Week High

    Sales occurred at $51.00 to $53.27, just below the 52-week high of $54.50, capitalizing on strong recent box office performance.

  • Pre-Planned Transaction

    The 10b5-1 plan was adopted May 19, 2026, reducing the signal of a change in management's outlook.

  • Remaining Holdings

    After the transactions, Gelfond holds 665,002 common shares, 975,654 options, and 231,562 restricted share units.


Analysis · IMAX · Industrial Applications And Services

Richard Gelfond, IMAX's CEO, exercised 356,757 stock options at $31.90 and immediately sold all resulting shares for $23.98 million under a pre-arranged 10b5-1 plan. The sales occurred at prices between $51.00 and $53.27, just below the 52-week high of $54.50. While the plan was established in May 2026, the execution near the stock's peak reflects a significant insider monetization event. The transaction represents 1.6% of the company's market cap, but because it is a 10b5-1 sale, it is less indicative of a change in management's outlook than a discretionary sale would be.

How filings like this one have moved

In the 30 days to Aug 22, 2026, 29.1% of the 2960 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.01%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, IMAX was trading at $52.74 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $2.9B. The 52-week trading range was $25.56 to $54.50. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

IMAX - Latest Insights

IMAX
Aug 20, 2026, 6:07 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $52.74
Real-time Price: $52.21 info
Change: -$0.530 (-1%) info
Market Cap: $2.892B info
IMAX
Aug 17, 2026, 8:30 AM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $52.27
Real-time Price: $52.21 info
Change: -$0.0612 (-0.12%) info
Market Cap: $2.892B info
IMAX
Aug 16, 2026, 8:00 PM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $53.04
Real-time Price: $52.21 info
Change: -$0.830 (-2%) info
Market Cap: $2.892B info
IMAX
Aug 10, 2026, 8:30 AM EDT
Source: BusinessWire
Importance Score:
9
Price at Filing: $49.06
Real-time Price: $52.21 info
Change: +$3.15 (+6%) info
Market Cap: $2.892B info
IMAX
Aug 09, 2026, 3:24 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $48.49
Real-time Price: $52.21 info
Change: +$3.72 (+8%) info
Market Cap: $2.892B info